Skip to main content
Log in

Survival and treatment of cranial and spinal chordomas: a population-based study

  • Original Article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Chordomas are rare, slow-growing malignant tumors. Given the paucity of data of the disease, the treatment strategies are disputed. We collected clinical and survival information of patients with chordoma diagnosed between 1975 and 2016 from the Surveillance, Epidemiology, and End Results database. A total of 1797 patients were initially enrolled, including 762 (42.4%) cranial and 1035 (57.6%) spinal chordoma. A total of 1504 patients were further evaluated after screening. In the cranial group, the surgery (gross total resection (GTR): p = 0.001 for overall survival (OS); p = 0.009 for cancer-specific survival (CSS)), tumor extension (distant metastasis: p = 0.001 for OS; p = 0.002 for CSS), and the age (p < 0.001 for OS) were independent prognostic factors for survival. In the spinal group, the age (p = 0.004), location (p < 0.001), GTR (p < 0.001), and tumor extension (distant metastasis, p < 0.001) were independent prognostic factors for OS; the age (p = 0.007), histological type (p < 0.001), GTR (p < 0.001), radiation (p = 0.018), chemotherapy (p = 0.006), and tumor extension (p < 0.001) were independent prognostic factors for CSS. In this large cohort, a significant association was noted between extent of resection and outcome. Even though adjuvant radiation or chemotherapy did not benefit patients with chordoma, the effect on prognosis can be explored in a further study based on our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Code availability

R software.

References

  1. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Kindblom JMM (2000) Prognostic Factor in Chordoma of Sacrum and Mobile Spine. Cancer-am Cancer Soc 88:2122–34

    CAS  Google Scholar 

  2. Bugoci DM, Girvigian MR, Chen JC, Miller MM, Rahimian J (2013) Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas. Am J Clin Oncol 36:404–10

    Article  CAS  Google Scholar 

  3. Brian P, Walcott A, Brian V, Nahed A, Ahmed M (2012) Chordoma: current concepts, management, and future directions. Lancet Oncol 13:e69-76

    Article  Google Scholar 

  4. Chordoma: Natural history and treatment results in 33 cases (1988) Chordoma: Natural history and treatment results in 33 cases. J Surg Oncol 37:185–91

  5. Coffin CM, Swanson PE, Wick MR, Dehner LP (1993) Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. Arch Pathol Lab Med 117:927–933

    CAS  PubMed  Google Scholar 

  6. Kerekes D, Rory Goodwin C, Karim Ahmed A, Verlaan J-J (2019) Local and Distant Recurrence in Resected Sacral Chordomas: A Systematic Review and Pooled Cohort Analysis. Global Spine J 9:191–201

    Article  Google Scholar 

  7. Fletcher CDM BJ, Hogendoorn PCW, Mertens F (2013) WHO Classification of Tumours of Soft Tissue and Bone. IARC S, Lyon, FR, pp 327–328

    Google Scholar 

  8. Frezza AM, Botta L, Trama A, Tos APD, Stacchiotti S (2018) Chordoma: update on disease, epidemiology, biology and medical therapies. Curr Opin Oncol 31:114–120

    Article  Google Scholar 

  9. Goodarzi A, Toussi A, Lechpammer M, Lee D, Shahlaie K (2017) Intradural chordoma of the cerebellopontine angle: case report and review. World Neurosurg 107:1052.e11-1052.e16

    Article  Google Scholar 

  10. Heffelfinger MJ, Dahlin DC, Maccarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer-Am Cancer Soc 32:410–420

    CAS  Google Scholar 

  11. Hsieh PC, Xu R, Sciubba DM, Mcgirt MJ, Gokaslan ZL (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine 34:2233–2239

    Article  Google Scholar 

  12. Hsieh PC, Xu R, Sciubba DM, Mcgirt MJ, Nelson C, Witham TF, Wolinksy JP, Gokaslan ZL (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas. Spine 34:2233–2239

    Article  Google Scholar 

  13. Jawad MU, Scully SP (2010) Surgery significantly improves survival in patients with chordoma. Spine 35:117–123

    Article  Google Scholar 

  14. Lee IJ, Lee RJ, Fahim DK (2017) Prognostic Factors and Survival Outcomes in Patients with Chordoma in the United States: A Population-Based Analysis. World Neurosurg 104:346–355

    Article  Google Scholar 

  15. Mcmaster ML, Goldstein AM, Bromley CM, Parry IDM (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes & Control Ccc 12:1

    Article  CAS  Google Scholar 

  16. Multicenter Phase II Trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas (2009) Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J Clin Oncol 27:3154-3160

  17. Rassi MS, Maher HM, Kaith A, Bi WL, Svetlana P, Dunn IF, Smith TR, Ossama AM (2017) Pediatric Clival Chordoma: A Curable Disease that Conforms to Collins’ Law. Neurosurgery 82:652–660

    Article  Google Scholar 

  18. Rotondo RL, Folkert W, Liebsch NJ, Chen YE, Pedlow FX, Schwab JH, Rosenberg AE, Nielsen GP, Szymonifka J, Ferreira AE (2015) High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine 23:788–97

    Article  Google Scholar 

  19. Sahyouni R, Goshtasbi K, Mahmoodi A, Chen JW (2018) A historical recount of chordoma. J Neurosurg Spine 28:422–428

    Article  Google Scholar 

  20. Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Kel OJ, Edler L, Scholz M, Debus J (2007) Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol 68:449–457

    Article  Google Scholar 

  21. Sibley RK, Day DL, Dehner LP, Trueworthy RC (1987) Metastasizing chordoma in early childhood: a pathological and immunohistochemical study with review of the literature. Pediatr Pathol 7:287–301

    CAS  PubMed  Google Scholar 

  22. Spiro IJ (1999) Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44:80

    Article  Google Scholar 

  23. Spjut HJ, Luse SA (1964) Chordoma: an electron microscopic study. Cancer-Am Cancer Soc 17:643–656

    CAS  Google Scholar 

  24. Stacchiotti S, Casali PG, Vullo SL, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17:211–219

    Article  Google Scholar 

  25. Tzortzidis F, Elahi F, Wright DC, Temkin N, Natarajan SK, Sekhar LN (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 58:1090–1098

    Article  Google Scholar 

  26. Wagner TD, Kobayashi W, Dean S, Goldberg SI, Kirsch DG, Suit HD, Hornicek FJ, Pedlow FX, Raskin KA, Springfield DS (2009) Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone. Int J Radiat Oncol Biol Phys 73:259–266

    Article  Google Scholar 

  27. Yagiz Yolcu, Waseem Wahood, Mohammed Ali, Alvi Panagiotis, Kerezoudis Scott (2019) Evaluating the Role of Adjuvant Radiotherapy in Management of Sacral and Vertebral Chordoma: Results from a National Database. World Neurosurg 127:e1137–e1144

    Article  Google Scholar 

  28. Yasuda M, Bresson D, Chibbaro S, Cornelius JF, Polivka M, Feuvret L, Takayasu M, George B (2012) Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients. Neurosurg Rev 35:171–183

    Article  Google Scholar 

  29. Yoneoka Y, Tsumartuma I, Fukuda M, Tamura T, Morii K, Tanaka R, Fujii Y (2008) Cranial base chordoma – long term outcome and review of the literature. Acta Neurochirurgica -Wien- 150:773–778

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conception and experimental design: all authors.

Acquisition of data: all authors.

Analysis and interpretation of data: all authors.

Drafting the article: Gui-Jun Zhang and Yu-Shi Cui.

Statistical analysis: Gui-Jun Zhang and Yu-Shi Cui.

Approved the final version of the manuscript on behalf of all authors: Huan Li.

Corresponding author

Correspondence to Huan Li.

Ethics declarations

Ethics approval

This study was approved by the Institutional Review Board.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, GJ., Cui, YS. & Li, H. Survival and treatment of cranial and spinal chordomas: a population-based study. Neurosurg Rev 45, 637–647 (2022). https://doi.org/10.1007/s10143-021-01583-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-021-01583-5

Keywords

Navigation